Does BAMLANIVIMAB Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with BAMLANIVIMAB. This represents 0.1% of all adverse event reports for BAMLANIVIMAB.
5
Reports of Malignant neoplasm progression with BAMLANIVIMAB
0.1%
of all BAMLANIVIMAB reports
5
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BAMLANIVIMAB?
Of the 5 reports, 5 (100.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BAMLANIVIMAB Cause?
Dyspnoea (833)
Infusion related reaction (663)
Pyrexia (641)
Chills (453)
Oxygen saturation decreased (448)
Nausea (422)
Covid-19 (346)
Cough (342)
Covid-19 pneumonia (313)
Hypoxia (310)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BAMLANIVIMAB Alternatives Have Lower Malignant neoplasm progression Risk?
BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB
BAMLANIVIMAB vs BARACLUDE
BAMLANIVIMAB vs BARICITINIB
BAMLANIVIMAB vs BARIUM
BAMLANIVIMAB vs BARNIDIPINE